Kembi Therapeutics
Business Services · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
AustraliaWebsite
www.kembi.com.auRevenue
<$5 MillionIndustry
About Kembi Therapeutics
Kembi Therapeutics Org Chart
Is Kembi Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Kembi Therapeutics launches new products
Check out if Kembi Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Kembi Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Kembi Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Kembi Therapeutics has new funding data
Earning: See what the market has to say on Kembi Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Kembi Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Kembi Therapeutics
Recommended Actions
Reach out to Masked Content who joined Kembi Therapeutics as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Kembi Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Kembi Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Kembi Therapeutics.
Kembi Therapeutics Tech Stack
A closer look at the technologies used by Kembi Therapeutics
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Kembi Therapeutics
Kembi Therapeutics is an Australian-founded clinical-stage biotechnology company that develops plasticity-targeting therapies designed to prevent and reverse treatment resistance in aggressive cancers. The company targets the biological mechanisms of cellular plasticity, which allow tumor cells to shift identity and evade targeted therapies. Its le... Read More